DE3063837D1 - Process for preparing imidazole derivatives - Google Patents

Process for preparing imidazole derivatives

Info

Publication number
DE3063837D1
DE3063837D1 DE8080102042T DE3063837T DE3063837D1 DE 3063837 D1 DE3063837 D1 DE 3063837D1 DE 8080102042 T DE8080102042 T DE 8080102042T DE 3063837 T DE3063837 T DE 3063837T DE 3063837 D1 DE3063837 D1 DE 3063837D1
Authority
DE
Germany
Prior art keywords
general formula
signifies
compound
see diagramm
formula see
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080102042T
Other languages
German (de)
English (en)
Inventor
Helmut Dr Link
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE3063837D1 publication Critical patent/DE3063837D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
DE8080102042T 1979-04-24 1980-04-16 Process for preparing imidazole derivatives Expired DE3063837D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH383779 1979-04-24

Publications (1)

Publication Number Publication Date
DE3063837D1 true DE3063837D1 (en) 1983-07-28

Family

ID=4264536

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080102042T Expired DE3063837D1 (en) 1979-04-24 1980-04-16 Process for preparing imidazole derivatives

Country Status (13)

Country Link
EP (1) EP0017976B1 (enExample)
JP (1) JPS55143974A (enExample)
KR (1) KR850000719B1 (enExample)
AT (1) ATE3860T1 (enExample)
CA (1) CA1135706A (enExample)
DE (1) DE3063837D1 (enExample)
DK (1) DK174480A (enExample)
ES (1) ES8104243A1 (enExample)
FI (1) FI801184A7 (enExample)
GR (1) GR67605B (enExample)
HU (1) HU184271B (enExample)
NO (1) NO801182L (enExample)
PT (1) PT71135B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2715402B1 (fr) * 1994-01-05 1996-10-04 Roussel Uclaf Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2724169B1 (fr) * 1994-09-06 1997-01-03 Roussel Uclaf Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
EP2299266A1 (en) 2003-12-19 2011-03-23 The Regents of the University of California Methods and materials for assessing prostate cancer therapies
NZ550102A (en) 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
BRPI0709771B1 (pt) 2006-03-27 2022-01-25 The Regents Of The University Of California Composto e composição farmacêutica
NZ596260A (en) * 2006-03-29 2013-05-31 Univ California Diarylthiohydantoin compounds
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
EP3124481B1 (en) 2010-02-16 2018-03-28 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
WO2014052237A1 (en) 2012-09-26 2014-04-03 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
EP2945628B1 (en) 2013-01-15 2020-04-15 Aragon Pharmaceuticals, Inc. Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR20240096623A (ko) 2017-10-16 2024-06-26 아라곤 파마슈티컬스, 인코포레이티드 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997037A (en) * 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
US3340070A (en) * 1963-08-23 1967-09-05 Shell Oil Co Artificial sweetening agent
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
IL55774A (en) * 1977-10-28 1982-04-30 Sparamedica Ag Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine

Also Published As

Publication number Publication date
GR67605B (enExample) 1981-08-31
KR850000719B1 (ko) 1985-05-23
EP0017976A3 (en) 1981-04-01
HU184271B (en) 1984-07-30
DK174480A (da) 1980-10-25
KR830002722A (ko) 1983-05-30
NO801182L (no) 1980-10-27
ATE3860T1 (de) 1983-07-15
ES490799A0 (es) 1981-04-16
EP0017976B1 (de) 1983-06-22
FI801184A7 (fi) 1981-01-01
PT71135B (en) 1981-08-07
ES8104243A1 (es) 1981-04-16
JPS55143974A (en) 1980-11-10
PT71135A (en) 1980-05-01
EP0017976A2 (de) 1980-10-29
CA1135706A (en) 1982-11-16

Similar Documents

Publication Publication Date Title
EP0017976A3 (en) Process for preparing imidazole derivatives and the starting materials used in this process
BG38639A3 (en) Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
GB1224591A (en) Improvements in or relating to phosphonic acid anhydrides
HU179545B (en) Compositions for plant growth regulation containing phthalamide acid
ES465208A1 (es) Un procedimiento para preparar compuestos de imidazolina
MY101645A (en) Phosphoric esters and process for preparing the same.
GB1394007A (en) Sulphoximines
FR2479813B1 (enExample)
GB1276277A (en) 2-chloroethane-(thiono)-phosphonic acid amido compounds, processes for their preparation, and their use for the regulation of plant growth
ES8308870A1 (es) Procedimiento para la preparacion de derivados de acido 5-(4-fenil-1-piperidinil) metil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico.
HU9300423D0 (en) Method for producing amino-methane-phosphonic acid and amino-methane-phosphinic one
ES8605529A1 (es) Procedimiento para la preparacion de acidos alfa-aminoal- quilfosfonicos y de acidos alfa-aminoalquilfosfinicos
SE8300432D0 (sv) Reaktiva kanelsyraderivat for framstellning av biologiskt aktiva amider
ES446187A1 (es) Un metodo de preparar nuevos compuestos de oxima-eter.
CA1273347C (enExample)
EP0500952A4 (en) Process for producing nitrogenous heterocycle
LU88287I2 (fr) Cyproternacetate (Climen)
ATE17851T1 (de) Imidazolylkarbonsaeure, deren derivate und herstellung.
DE3264330D1 (en) Process for the preparation of cycloalkenon derivatives
ES8403442A1 (es) Un procedimiento de preparacion de 1-2(arilmetil)aril-4-oxociclohexanol-oximas.
EP0041576A4 (en) 1- (2,6-DICHLORPHENYL) -2-QUINOLINONE-IMIN-3-CARBOXYLIC ACID, PRODUCTION OF THE COMPOUND AND CONTAINING PAIN-RELIEFING, ANTI-FLAMMING COMPOSITION.
GB1526607A (en) Zearalin ethers
ES8302005A1 (es) Procedimiento para preparar compuestos cefalosporanicos
ES461718A1 (es) Procedimiento para la obtencion de composiciones herbicidas
DE3062286D1 (en) 9-chloro-prednisolone derivatives, their preparation and their utilization

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee